-transparent.png){kind=logo}
The effect of long-term phenytoin therapy on serum triglyceride and cholesterol levels in 20 patients with epilepsy was investigated. In patients followed up for six years, phenytoin treatment was associated with an increase in serum triglyceride and cholesterol levels. The most significant increases in lipid levels were measured during the first months of therapy, whereafter values generally tended to decrease. The elevation in serum triglyceride concentration was relatively greater than that in serum cholesterol level. Cholesterol concentrations, however, remained high for a longer period. The results demonstrate that phenytoin therapy for epilepsy is associated with a rise in serum triglyceride and cholesterol levels, the degree of which seems to be related to the duration of the treatment. The changes presumably reflect phenytoin effects on hepatic lipid metabolism.
P V Luoma, and
M I Reunanen, and
E A Sotaniemi
November 1976,
Acta neurologica Scandinavica,
P V Luoma, and
M I Reunanen, and
E A Sotaniemi
October 1975,
British medical journal,
P V Luoma, and
M I Reunanen, and
E A Sotaniemi
March 1979,
Obstetrics and gynecology,
P V Luoma, and
M I Reunanen, and
E A Sotaniemi
January 1983,
Acta neurologica Scandinavica. Supplementum,
P V Luoma, and
M I Reunanen, and
E A Sotaniemi
January 1990,
Zeitschrift fur Versuchstierkunde,
P V Luoma, and
M I Reunanen, and
E A Sotaniemi
January 2014,
Case reports in oncology,
P V Luoma, and
M I Reunanen, and
E A Sotaniemi
August 1975,
Lancet (London, England),
P V Luoma, and
M I Reunanen, and
E A Sotaniemi
April 1968,
Cardiovascular research,
P V Luoma, and
M I Reunanen, and
E A Sotaniemi
December 1975,
Current therapeutic research, clinical and experimental,
P V Luoma, and
M I Reunanen, and
E A Sotaniemi
January 1994,
Neurologia i neurochirurgia polska,
